Table 3.
Comparison of baseline characteristics depending on the viral response status at week 24.
| Patient characteristics at baseline (n = 33) | Viral response at week 24 (n = 19) | Viral non-response at week 24 (n = 3) | Intermediate viral response at week 24 (n = 11) | Post hoc p value |
|---|---|---|---|---|
| ALT U/L, mean ± SD | 114 ± 85 | 140 ± 10 | 109 ± 64 | 0.85∗, 0.98∗∗, 0.80∗∗∗ |
| Age, years ± SD | 49 ± 8 | 36 ± 9 | 47 ± 16 | 0.20∗, 0.93∗∗, 0.32∗∗∗ |
| Cirrhosis, n | 12/19 | 2/3 | 4/11 | 0.33 (overall group comparison) |
| Platelets ∗103/μl, median | 133 | 158 | 130 | 0.52∗, 0.86∗∗, 0.65∗∗∗ |
∗Response vs. non-response, ∗∗Response vs. intermediate response, ∗∗∗Non-response vs. intermediate response.
Data were compared by univariate ANOVA followed by a Tukey post hoc test. A Pearson Chi-square test was used for the presence of cirrhosis.
ALT, alanine aminotransferase.